Traveler's Diarrhea Therapeutics Market Report

Global and Region Traveler's Diarrhea Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：141
  • REPORT CODE：GMM1004712
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week. Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.

    The classification of Traveler’s Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.

    The report details the trend, potential and market size of Traveler's Diarrhea Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Traveler's Diarrhea Therapeuticsmarket, defines the market attractiveness level of Traveler's Diarrhea Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Traveler's Diarrhea Therapeutics industry, describes the types of Traveler's Diarrhea Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Traveler's Diarrhea Therapeutics market and the development prospects and opportunities of Traveler's Diarrhea Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Traveler's Diarrhea Therapeutics market in Chapter 13.

    By Player:

    • P&G

    • Salix Pharmaceuticals

    • Immuron

    • Otsuka Pharma

    • Johnson & Johnson

    • Shanghai United Cell

    • Valneva

    • Livzon

    • PaxVax

    By Type:

    • Immunization

    • Non-antibiotic Agents

    • Antibiotics

    • Anti-Motility Agents

    • Other

    By End-User:

    • Adult Traveler's Diarrhea

    • Children Traveler's Diarrhea

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Traveler's Diarrhea Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Traveler's Diarrhea Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Traveler's Diarrhea Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Traveler's Diarrhea Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Traveler's Diarrhea Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Traveler's Diarrhea Therapeutics Consumption (2017-2022)

    • 7.2 United States Traveler's Diarrhea Therapeutics Consumption (2017-2022)

    • 7.3 Europe Traveler's Diarrhea Therapeutics Consumption (2017-2022)

    • 7.4 China Traveler's Diarrhea Therapeutics Consumption (2017-2022)

    • 7.5 Japan Traveler's Diarrhea Therapeutics Consumption (2017-2022)

    • 7.6 India Traveler's Diarrhea Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Traveler's Diarrhea Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Traveler's Diarrhea Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Traveler's Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Traveler's Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Traveler's Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Traveler's Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Traveler's Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Traveler's Diarrhea Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Traveler's Diarrhea Therapeutics Consumption Forecast (2022-2028)

    9 Global Traveler's Diarrhea Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Traveler's Diarrhea Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunization Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-antibiotic Agents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antibiotics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Anti-Motility Agents Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Traveler's Diarrhea Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adult Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Children Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    10 Global Traveler's Diarrhea Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Immunization Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-antibiotic Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Anti-Motility Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Adult Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Children Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    11 Global Traveler's Diarrhea Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Traveler's Diarrhea Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Traveler's Diarrhea Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Traveler's Diarrhea Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Traveler's Diarrhea Therapeutics Market Competitive Analysis

    • 14.1 P&G

      • 14.1.1 P&G Company Details

      • 14.1.2 P&G Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 P&G Traveler's Diarrhea Therapeutics Product and Service

    • 14.2 Salix Pharmaceuticals

      • 14.2.1 Salix Pharmaceuticals Company Details

      • 14.2.2 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product and Service

    • 14.3 Immuron

      • 14.3.1 Immuron Company Details

      • 14.3.2 Immuron Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Immuron Traveler's Diarrhea Therapeutics Product and Service

    • 14.4 Otsuka Pharma

      • 14.4.1 Otsuka Pharma Company Details

      • 14.4.2 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Product and Service

    • 14.5 Johnson & Johnson

      • 14.5.1 Johnson & Johnson Company Details

      • 14.5.2 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Product and Service

    • 14.6 Shanghai United Cell

      • 14.6.1 Shanghai United Cell Company Details

      • 14.6.2 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Product and Service

    • 14.7 Valneva

      • 14.7.1 Valneva Company Details

      • 14.7.2 Valneva Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Valneva Traveler's Diarrhea Therapeutics Product and Service

    • 14.8 Livzon

      • 14.8.1 Livzon Company Details

      • 14.8.2 Livzon Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Livzon Traveler's Diarrhea Therapeutics Product and Service

    • 14.9 PaxVax

      • 14.9.1 PaxVax Company Details

      • 14.9.2 PaxVax Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 PaxVax Traveler's Diarrhea Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Traveler's Diarrhea Therapeutics

    • Figure Traveler's Diarrhea Therapeutics Picture

    • Table Global Traveler's Diarrhea Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Traveler's Diarrhea Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Traveler's Diarrhea Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Traveler's Diarrhea Therapeutics Consumption by Country (2017-2022)

    • Figure United States Traveler's Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Traveler's Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Traveler's Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Traveler's Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Traveler's Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Traveler's Diarrhea Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Traveler's Diarrhea Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Traveler's Diarrhea Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunization Consumption and Growth Rate (2017-2022)

    • Figure Global Non-antibiotic Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotics Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-Motility Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Global Children Traveler's Diarrhea Consumption and Growth Rate (2017-2022)

    • Figure Global Immunization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-antibiotic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-Motility Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Traveler's Diarrhea Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Traveler's Diarrhea Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Traveler's Diarrhea Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table P&G (Foundation Year, Company Profile and etc.)

    • Table P&G Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table P&G Traveler's Diarrhea Therapeutics Product and Service

    • Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product and Service

    • Table Immuron (Foundation Year, Company Profile and etc.)

    • Table Immuron Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immuron Traveler's Diarrhea Therapeutics Product and Service

    • Table Otsuka Pharma (Foundation Year, Company Profile and etc.)

    • Table Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Pharma Traveler's Diarrhea Therapeutics Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Traveler's Diarrhea Therapeutics Product and Service

    • Table Shanghai United Cell (Foundation Year, Company Profile and etc.)

    • Table Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai United Cell Traveler's Diarrhea Therapeutics Product and Service

    • Table Valneva (Foundation Year, Company Profile and etc.)

    • Table Valneva Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Traveler's Diarrhea Therapeutics Product and Service

    • Table Livzon (Foundation Year, Company Profile and etc.)

    • Table Livzon Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Livzon Traveler's Diarrhea Therapeutics Product and Service

    • Table PaxVax (Foundation Year, Company Profile and etc.)

    • Table PaxVax Traveler's Diarrhea Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Traveler's Diarrhea Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US